Impact of absorption and transport on intelligent therapeutics and nanoscale delivery of protein therapeutic agents

Chemical Engineering Science

Volumn 64, Issue 22, 2009, Pages 4553-4565

  Peppas, Nicholas A ^a   Carr, Daniel A ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Absorption; Drug delivery; Pharmaceuticals; Polymers; Proteins; Transport

Indexed keywords

BLOOD CONCENTRATIONS; DYNAMIC NATURE; GASTROINTESTINAL TRACT; INTELLIGENT THERAPEUTICS; LABORATORY TECHNIQUES; MATERIAL STRUCTURE; MATERIALS DESIGN; NANO SCALE; NEW SYSTEM; ORAL ADMINISTRATION; ORAL DELIVERY; ORAL ROUTE; PATIENT COMPLIANCE; PHARMACEUTICALS; PROTEIN TRANSPORT; QUALITY OF LIFE; STIMULI-SENSITIVE; THERAPEUTIC AGENTS; THERAPEUTIC PROTEIN; TRANSPORT;

BIOLOGICAL MATERIALS; CELL CULTURE; CELL MEMBRANES; DRUG DELIVERY; INTELLIGENT AGENTS; NANOTECHNOLOGY; PROTEINS;

ABSORPTION;

EID: 70349626034     PISSN: 00092509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ces.2009.04.050     Document Type: Article

References (156)

1. Agu R.U., Ugwoke M.I., Armand M., Kinget R., and Verbeke N. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respiratory Research 2 4 (2001) 198-209
2. Ahsan F., Arnold J., Meezan E., and Pillion D.J. Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats. Pharmaceutical Research 18 12 (2001) 1742-1746
3. American Diabetes Association (cited 24 April 2008). Total prevalence of diabetes & pre-diabetes. Available from: 〈http://www.diabetes.org/diabetes-statistics/prevalence.jsp〉.
4. Amin A., Shah T., Patel J., and Gajjar A. Non-invasive insulin delivery technologies: current trends and future prospects. Drug Delivery Technology 6 3 (2006) 48-60
5. Amin A., Shah T., Patel J., and Gajjar A. Non-invasive insulin. Drug Delivery Technology 8 3 (2008) 43-48
6. Arora P., Sharma S., and Garg S. Permeability issues in nasal drug delivery. Drug Discovery Today 7 18 (2002) 967-975
7. Artursson P. Epithelial transport of drugs I. A model for studying the transport of drugs (β-blocking agents) over an intestinal epithelial cell line (Caco-2). Journal of Pharmaceutical Science 79 (1990) 1123-1129
8. Artursson P., Palm K., and Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Advanced Drug Delivery Reviews 46 (2001) 27-43
9. Audus K.L., Bartel R.L., Hidalgo I.J., and Borchardt R.T. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharmaceutical Research 7 (1990) 435-451
10. Aungst B.J. Intestinal permeation enhancers. Journal of Pharmaceutical Sciences 89 4 (2000) 429-442
11. Azria M. Possible mechanisms of the analgesic action of calcitonin. Bone 30 5 (2002) 80S-83S
12. Bajpai A., and Menon P.S.N. Growth hormone therapy. Indian Journal of Pediatrics 72 2 (2005) 139-144
13. Bekturov E.A., and Bimendina L.A. Interpolymer complexes. Advances in Polymer Science 43 (1981) 100-147
14. Bell C.L., and Peppas N.A. Swelling/syneresis phenomena in gel-forming interpolymer complexes. Journal of Biomaterials Science, Polymer Edition 7 (1996) 671-683
15. Bell C.L., and Peppas N.A. Modulation of drug permeation through interpolymer complexed hydrogels for drug delivery applications. Journal of Controlled Release 39 (1996) 201-207
16. Bernkop-Schnurch A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. Journal of Controlled Release 52 1-2 (1998) 1-16
17. Bernkop-Schnürch A. Thiomers: a new generation of mucoadhesive polymers. Advanced Drug Delivery Reviews 57 11 (2005) 1569-1582
18. Bernkop-Schnürch A., Brandt U.M., and Clausen A.E. Synthesis and in vitro evaluation of chitosan-cysteine conjugates. Scientia Pharmaceutica 67 (1999) 196-208
19. Bernkop-Schnurch A., Hoffer M.H., and Kafedjiiski K. Thiomers for oral delivery of hydrophilic macromolecular drugs. Expert Opinion on Drug Delivery 1 1 (2004) 87-98
20. Bernkop-Schnurch A., Kast C.E., and Richter M.F. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. Journal of Controlled Release 71 3 (2001) 277-285
21. Besheer A., Wood K.M., Peppas N.A., and Mader K. Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration. Journal of Controlled Release 111 1-2 (2006) 73-80
22. Blanchette J., Kavimandan N., and Peppas N.A. Principles of transmucosal delivery of therapeutic agents. Biomedicine and Pharmacotherapy 58 3 (2004) 142-151
23. Blanchette J., and Peppas N.A. Cellular evaluation of oral chemotherapy carriers. Journal of Biomedical Materials Research, Part A 72A 4 (2005) 381-388
24. Blanchette J., and Peppas N.A. Oral chemotherapeutic delivery: design and cellular response. Annals of Biomedical Engineering 33 2 (2005) 142-149
25. Bosquillon C., Préat V., and Vanbever R. Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. Journal of Controlled Release 96 2 (2004) 233-244
26. Braun A., Hämmerle S., Suda K., Rothen-Rutishauser B., Günthert M., Krämer S.D., and Wunderli-Allenspach H. Cell cultures as tools in biopharmacy. European Journal of Pharmaceutical Science 11 (2000) S51-S60
27. Brønsted H., and Kopeček J. Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation. Pharmaceutical Research 9 (1992) 1540-1545
28. Calceti P., Salmaso S., Walker G., and Bernkop-Schnürch A. Development and in vivo evaluation of an oral insulin-PEG delivery system. European Journal of Pharmaceutical Sciences 22 4 (2004) 315-323
29. Carino G.P., and Mathiowitz E. Oral insulin delivery. Advanced Drug Delivery Reviews 35 2-3 (1999) 249-257
30. Carrel A.L., Moerchen V., Myers S.E., Bekx M.T., Whitman B.Y., and Allen D.B. Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome. Journal of Pediatrics 145 6 (2004) 744-749
31. Cheng Y.-H., Dyer A.M., Jabbal-Gill I., Hinchcliffe M., Nankervis R., Smith A., and Watts P. Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations. European Journal of Pharmaceutical Sciences 26 1 (2005) 9-15
32. Chesnut C.H., Azria M., Silverman S., Engelhardt M., Olson M., and Mindeholm L. Salmon calcitonin: a review of current and future therapeutic indications. Osteoporosis International 19 4 (2008) 479-491
33. Chickering D.E., and Mathiowitz E. Definitions, mechanisms, and theories of bioadhesion. In: Mathiowitz E., Chickering D.E., and Lehr C.-M. (Eds). Bioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches, and Development (1999), Marcel Dekker, New York
34. Cnop M., Welsh N., Jonas J.C., Jorns A., Lenzen S., and Eizirik D.L. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes-many differences, few similarities. Diabetes 54 (2005) S97-S107
35. Cogburn J.N., Donovan M.G., and Schasteen C.S. A model of human small intestinal absorptive cells. 1. Transport barrier. Pharmaceutical Research 8 (1991) 210-216
36. Copp D.H., Davidson A.G., Henze K.G., Cheney B.A., and Cameron E.C. Evidence for calcitonin-a new hormone from parathyroid that lowers blood calcium. Endocrinology 70 5 (1962) 638-649
37. Cui Z.R., and Mumper R.J. Buccal transmucosal delivery of calcitonin in rabbits using thin-film composites. Pharmaceutical Research 19 12 (2002) 1901-1906
38. Daughaday W.H., and Harvey S. Growth hormone release: pathophysiological dysfunction. In: Harvey S., Scanes C.G., and Daughaday W.H. (Eds). Growth Hormone (1995), CRC Press, Boca Raton
39. Dodou D., Breedveld P., and Wieringa P.A. Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications. European Journal of Pharmaceutics and Biopharmaceutics 60 1 (2005) 1-16
40. Dyer A.M., Hinchcliffe M., Watts P., Castile J., Jabbal-Gill I., Nankervis R., Smith A., and Illum L. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharmaceutical Research 19 7 (2002) 998-1008
41. Ellerington M.C., Hillard T.C., Whitcroft S.I.J., Marsh M.S., Lees B., Banks L.M., Whitehead M.I., and Stevenson J.C. Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis. Calcified Tissue International 59 1 (1996) 6-11
42. Espinal, J., 1989. Understanding insulin action: principles and molecular mechanisms. Ellis Horwood Limited, Chichester, England.
43. Fasano A., and Uzzau S. Modulation of intestinal tight junctions by zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. Journal of Clinical Investigation 99 (1997) 1158-1164
44. Fasano A. Innovative strategies for the oral delivery of drugs and peptides. Trends in Biotechnology 16 4 (1998) 152-157
45. Fix J.A. Oral controlled release technology for peptides: status and future prospects. Pharmaceutical Research 13 (1996) 1760-1764
46. Foss A.C., and Peppas N.A. Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with Caco-2 Cultures. European Journal of Pharmaceutics and Biopharmaceutics 57 (2004) 447-455
47. Foss A.C., Goto T., Morishita M., and Peppas N.A. Development of acrylic-based copolymers for oral insulin delivery. European Journal of Pharmaceutics and Biopharmaceutics 57 2 (2004) 163-169
48. 2-antagonist. Pharmaceutical Research 15 (1998) 53-57
49. Generex Biotechnology (cited 2 May 2008); Available from: 〈http://www.generex.com/index.php〉.
50. Gerich J.E. Novel insulins: expanding options in diabetes management. American Journal of Medicine 113 4 (2002) 308-316
51. Gharib H. American Association of clinical endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children-2003 update. Endocrine Practice 9 1 (2003) 64-76
52. Goto T., Morishita M., Kavimandan N.J., Takayama K., and Peppas N.A. Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats. Journal of Pharmaceutical Sciences 95 2 (2006) 462-469
53. Grabovac V., Guggi D., and Bernkop-Schnürch A. Comparison of the mucoadhesive properties of various polymers. Advanced Drug Delivery Reviews 57 11 (2005) 1713-1723
54. Granger D.N., Barrowman J.A., and Kvietys P.R. Clinical Gastrointestinal Physiology (1985), W.B. Saunders Company, Philadelphia
55. Guggi D., Kast C.E., and Bernkop-Schnurch A. In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix. Pharmaceutical Research 20 12 (2003) 1989-1994
56. Hamman J.H., Enslin G.M., and Kotze A.F. Oral delivery of peptide drugs-barriers and developments. BioDrugs 19 3 (2005) 165-177
57. Harvey S. Growth hormone storage. In: Harvey S., Scanes C.G., and Daughaday W.H. (Eds). Growth Hormone (1995), CRC Press, Boca Raton
58. Harvey S. Growth hormone synthesis. In: Harvey S., Scanes C.G., and Daughaday W.H. (Eds). Growth Hormone (1995), CRC Press, Boca Raton
59. Heller S., Kozlovski P., and Kurtzhals P. Insulin's 85th anniversary-an enduring medical miracle. Diabetes Research and Clinical Practice 78 2 (2007) 149-158
60. Hoffman, A.S., 2001. Hydrogels for biomedical applications. In: Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trials. pp. 62-73.
61. Hovgaard L., Jacobs H., Mazer N.A., and Kim S.W. Stabilization of insulin by alkylmaltosides. A. Spectroscopic evaluation. International Journal of Pharmaceutics 132 1-2 (1996) 107-113
62. Hurni M.A., Noach A.B.J., Blom-Roosemalen C.M., de Boer A.G., Nagelkerke J.F., and Breimer D.D. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy. The Journal of Pharmacology and Experimental Therapeutics 267 (1993) 942-950
63. Hwang S.-J., Park H., and Park K. Gastric retentive drug-delivery systems. Critical Reviews in Therapeutic Drug Carrier Systems 15 3 (1998) 243-284
64. Ichikawa, H., Peppas, N.A., 2001. Synthesis and characterization of pH-responsive nanosized hydrogels of poly(methacrylic acid-g-ethylene glycol) for oral peptide delivery. In: Proceedings minutes, pp. 261-264.
65. Johnson L.R. Digestion and absorption. In: Johnson L.R. (Ed). Gastrointestinal Physiology. sixth ed (2001), Mosby, St. Louis
66. Kararli T.T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory-animals. Biopharmaceutics and Drug Disposition 16 5 (1995) 351-380
67. Kashyap N., Kumar N., and Kumar M. Hydrogels for pharmaceutical and biomedical applications. Critical Reviews in Therapeutic Drug Carrier Systems 22 2 (2005) 107-149
68. Kast C.E., and Bernkop-Schnurch A. Thiolated polymers-thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 22 17 (2001) 2345-2352
69. Kast C.E., Guggi D., Langoth N., and Bernkop-Schnurch A. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil. Pharmaceutical Research 20 6 (2003) 931-936
70. Kavimandan N.J., Losi E., and Peppas N.A. Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates. Biomaterials 27 20 (2006) 3846-3854
71. Kim B., and Peppas N.A. Analysis of molecular interactions in poly(methacrylic acid-g-ethylene glycol) hydrogels. Polymer 44 13 (2003) 3701-3707
72. Kissel T., and Werner U. Nasal delivery of peptides: an in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium. Journal of Controlled Release 53 1-3 (1998) 195-203
73. Klausner E.A., Lavy E., Friedman M., and Hoffman A. Expandable gastroretentive dosage forms. Journal of Controlled Release 90 2 (2003) 143-162
74. Klier J., Scranton A.B., and Peppas N.A. Self associating networks of Poly(methacrylic acid-g-ethylene glycol). Macromolecules 23 (1990) 4944-4949
75. Knipp G.T., Ho N.F.H., Barsuhn C.L., and Borchard R.T. Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size. Journal of Pharmaceutical Research 86 10 (1997) 1105-1110
76. Kopeček J., Kopečková P., Brønsted H., Rahti R., Říhová B., Yeh P.-Y., and Ikesue K. Polymers for colon-specific drug delivery. Journal of Controlled Release 19 (1992) 121-130
77. Kuzuya T., Nakagawa S., Satoh J., Kanazawa Y., Iwamoto Y., Kobayashi M., Nanjo K., Sasaki A., Seino Y., Ito C., Shima K., Nonaka K., and Kadowaki T. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Research and Clinical Practice 55 1 (2002) 65-85
78. Landin-Wilhelmsen K., Bryman I., and Wilhelmsen L. Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. Journal of Clinical Endocrinology and Metabolism 86 9 (2001) 4166-4170
79. Langer R., and Peppas N.A. Advances in biomaterials, drug delivery, and bionanotechnology. A.I.Ch.E. Journal 49 12 (2003) 2990-3006
80. Larhed A.W., Artursson P., Gråsjö J., and Björk E. Diffusion of drugs in native and purified gastrointestinal mucus. Journal of Pharmaceutical Sciences 86 6 (1997) 660-665
81. Leader B., Baca Q.J., and Golan D.E. Protein therapeutics: a summary and pharmacological classification. Nature Reviews Drug Discovery 7 (2008) 21-39
82. Lee V.H.L., Yamamoto A., and Kompella V.B. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Critical Reviews in Therapeutic Drug Carrier Systems 8 (1991) 91-192
83. Lee Y.H., and Sinko P.J. Oral delivery of salmon calcitonin. Advanced Drug Delivery Reviews 42 3 (2000) 225-238
84. Leitner V.M., Guggi D., and Bernkop-Schnurch A. Thiomers in noninvasive polypeptide delivery: in vitro and in vivo characterization of a polycarbophil-cysteine/glutathione gel formulation for human growth hormone. Journal of Pharmaceutical Sciences 93 7 (2004) 1682-1691
85. Leitner V.M., Guggi D., Krauland A.H., and Bernkop-Schnurch A. Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system. Journal of Controlled Release 100 1 (2004) 87-95
86. Leitner V.M., Walker G.F., and Bernkop-Schnurch A. Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. European Journal of Pharmaceutics and Biopharmaceutics 56 2 (2003) 207-214
87. Lopez J.E., and Peppas N.A. Effect of poly (ethylene glycol) molecular weight and microparticle size on oral insulin delivery from P(MAA-g-EG) microparticles. Drug Development and Industrial Pharmacy 30 5 (2004) 497-504
88. Lowman A.M., Morishita M., Kajita M., Nagai T., and Peppas N.A. Oral delivery of insulin using pH-responsive complexation gels. Journal of Pharmaceutical Sciences 88 9 (1999) 933-937
89. Lowman A.M., and Peppas N.A. Analysis of the complexation/decomplexation phenomena in graft polymer networks. Macromolecules 30 (1997) 4959-4965
90. Lowman A.M., and Peppas N.A. Hydrogels. In: Mathiowitz E. (Ed). Encyclopedia of Controlled Drug Delivery vol. 1 (1999), Wiley, New York
91. Lowman A.M., and Peppas N.A. Molecular analysis of interpolymer complexation in graft copolymer networks. Polymer 41 1 (2000) 73-80
92. Lueβen H.L., Rentel C.O., Kotzé A.F., Lehr C.M., de Boer A.G., Verhoef J.C., and Junginger H.E. Mucoadhesive polymers and peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro. Journal of Controlled Release 45 (1997) 15-23
93. Lyritis G.P., Ioannidis G.V., Karachalios T., Roidis N., Kataxaki E., Papaioannou N., Kaloudis J., and Galanos A. Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study. Clinical Journal of Pain 15 4 (1999) 284-289
94. Madsen F., and Peppas N.A. Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition. Biomaterials 20 18 (1999) 1701-1708
95. Marschutz M.K., Caliceti P., and Bernkop-Schnurch A. Design and in vivo evaluation of an oral delivery system for insulin. Pharmaceutical Research 17 12 (2000) 1468-1474
96. Mathiowitz E., Chickering D., Jacob J.S., and Santos C. Bioadhesive drug delivery systems. In: Mathiowitz E. (Ed). Encyclopedia of Controlled Drug Delivery vol. 1 (1999), Wiley, New York
97. Morimoto K., Katsumata H., Yabuta T., Iwanaga K., Kakemi M., Tabata Y., and Ikada Y. Gelatin microspheres as a pulmonary delivery system: evaluation of salmon calcitonin absorption. Journal of Pharmacy and Pharmacology 52 6 (2000) 611-617
98. Morishita M., Goto M., Takayama K., and Peppas N.A. Oral insulin delivery systems based on complexation polymer hydrogels. Journal of Drug Delivery Science and Technology 16 1 (2006) 19-24
99. Morishita M., Goto T., Peppas N.A., Joseph J.I., Torjman M.C., Munsick C., Nakamura K., Yamagata T., Takayama K., and Lowman A.M. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. Journal of Controlled Release 97 1 (2004) 115-124
100. Moriyama K., Ooya T., and Yui N. Hyaluronic acid grafted with poly(ethylene glycol) as a novel peptide formulation. Journal of Controlled Release 59 1 (1999) 77-86
101. Nakamura K., Murray R.J., Joseph J.I., Peppas N.A., Morishita M., and Lowman A.M. Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. Journal of Controlled Release 95 3 (2004) 589-599
102. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2005. 2005, US Department of Health and Human Services, Centers for Disease Control and Prevention: Atlanta, GA.
103. Nerurkar M.M., Burton P.S., and Borchardt R.T. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharmaceutical Research 13 (1996) 528-534
104. Nicolazzo J.A., Reed B.L., and Finnin B.C. Buccal penetration enhancers-how do they really work?. Journal of Controlled Release 105 1-2 (2005) 1-15
105. Nir Y., Paz A., Sabo E., and Potasman I. Fear of injections in young adults: prevalence and associations. American Journal of Tropical Medicine and Hygiene 68 3 (2003) 341-344
106. Opar A. Another blow for inhaled protein therapeutics. Nature Reviews Drug Discovery 7 (2008) 189-190
107. Overgaard K., Hansen M.A., Jensen S.B., and Christiansen C. Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis-a dose-response study. British Medical Journal 305 6853 (1992) 556-561
108. Overgaard K., Riis B.J., Christiansen C., and Hansen M.A. Effect of salcatonin given intranasally on early postmenopausal bone loss. British Medical Journal 299 6697 (1989) 477-479
109. Owens D.R., Zinman B., and Bolli G. Alternative routes of insulin delivery. Diabetic Medicine 20 11 (2003) 886-898
110. Pade V., and Stavchansky S. Link between drug absorption solubility and permeability measurements in Caco-2 cells. Journal of Pharmaceutical Science 87 (1998) 1604-1607
111. Papapoulos S.E. Paget's disease of bone: clinical, pathogenetic and therapeutic aspects. Baillière's Clinical Endocrinology and Metabolism 11 1 (1997) 117-143
112. Partanen T.-M., and Rissanen A. Insulin injection practices. Practical Diabetes International 17 8 (2000) 252-254
113. Peppas N.A. Hydrogels. In: Ratner B.D., Hoffman A.S., Schoen F.J., and Lemons J.E. (Eds). Biomaterials Science. second ed (2004), Elsevier Academic Press, San Diego, CA
114. Peppas N.A. Kinetics of smart hydrogels. In: Yui N., Mrsny R., and Park K. (Eds). Reflexive Polymers and Hydrogels: Understanding and Designing Fast-Responsive Polymeric Systems (2004), CRC Press, Boca Raton, FL
115. Peppas N.A. Drug delivery using smart polymers: recent advances. In: Galaev I., and Mattiasson B. (Eds). Smart Polymers: Applications in Biotechnology and Biomedicine (2007), CRC Press, Boca Raton, FL
116. Peppas N.A., Bures P., Leobandung W., and Ichikawa H. Hydrogels in pharmaceutical formulations. European Journal of Pharmaceutics and Biopharmaceutics 50 1 (2000) 27-46
117. Peppas N.A., Hansen P.J., and Buri P.A. A theory of molecular diffusion in the intestinal mucus. International Journal of Pharmaceutics 20 (1984) 107-118
118. Peppas N.A., and Klier J. Controlled release by using poly(ethylene glycol oxide-g-methacrylic acid) hydrogels. Journal of Controlled Release 16 (1991) 203-214
119. Peppas N.A., and Langer R. New challenges in biomaterials. Science 263 (1994) 1715-1720
120. Peppas N.A., and Mikos A.G. In: Peppas N.A. (Ed). Preparation Methods and Structure of Hydrogels (1986), CRC Press, Boca Raton, FL
121. Perakslis E., Tuesca A., and Lowman A. Complexation hydrogels for oral protein delivery: an in vitro assessment of the insulin transport-enhancing effects following dissolution in simulated digestive fluids. Journal of Biomaterials Science, Polymer Edition 18 12 (2007) 1475-1490
122. Pinkerton J.V., and Dalkin A.C. Combination therapy for treatment of osteoporosis: a review. American Journal of Obstetrics and Gynecology 197 6 (2007) 559-565
123. Podichetty V.K., Segal A.M., Lieber M., and Mazanec D.J. Effectiveness of salmon calcitonin nasal spray in the treatment of lumbar canal stenosis-a double-blind, randomized, placebo-controlled, parallel group trial. Spine 29 21 (2004) 2343-2349
124. Ponchel G., and Irache J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Advanced Drug Delivery Reviews 34 (1998) 191-219
125. Pondel M. Calcitonin and calcitonin receptors: bone and beyond. International Journal of Experimental Pathology 81 6 (2000) 405-422
126. Poór G., Donáth J., Fornet B., and Cooper C. Epidemiology of Paget's disease in Europe: the prevalence is decreasing. Journal of Bone and Mineral Research 21 10 (2006) 1545-1549
127. Portero A., Teijeiro-Osorio D., Alonso M.J., and Remuñán-López C. Development of chitosan sponges for buccal administration of insulin. Carbohydrate Polymers 68 4 (2007) 617-625
128. Pringels E., Callens C., Vervaet C., Dumont F., Slegers G., Foreman P., and Remon J.P. Influence of deposition and spray pattern of nasal powders on insulin bioavailability. International Journal of Pharmaceutics 310 1-2 (2006) 1-7
129. Rabkin R., Gottheiner T.I., and Fang V.S. Removal and excretion of immunoreactive rat growth-hormone by the isolated kidney. American Journal of Physiology 240 4 (1981) F282-F287
130. Read N.W., and Sugden K. Gastrointestinal dynamics and pharmacology for the optimum design of controlled-release oral dosage forms. CRC Critical Reviews in Therapeutic Drug Carrier Systems 4 3 (1988) 221-263
131. Robinson J.R. Rationale of bioadhesion/mucoadhesion. In: Gurny R., and Junginger H.E. (Eds). Bioadhesion-Possibilities and Future Trends (1989), Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany
132. Ross S.A., Gulve E.A., and Wang M.H. Chemistry and biochemistry of type 2 diabetes. Chemical Reviews 104 3 (2004) 1255-1282
133. Ruppar D. Oral delivery. Drug Delivery Technology 8 3 (2008) 50-51
134. Salama N.N., Eddington N.D., and Fasano A. Tight junction modulation and its relationship to drug delivery. Advanced Drug Delivery Reviews 58 1 (2006) 15-28
135. Salama N.N., Fasano A., Thakar M., and Eddington N.D. The effect of Delta G on the transport and oral absorption of macromolecules. Journal of Pharmaceutical Sciences 93 5 (2004) 1310-1319
136. Salamat-Miller N., Chittchang M., and Johnston T.P. The use of mucoadhesive polymers in buccal drug delivery. Advanced Drug Delivery Reviews 57 11 (2005) 1666-1691
137. Schipper N.G.M., Vårum K.M., and Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs. 1: influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharmaceutical Research 13 (1996) 1686-1692
138. Serra L., Domenech J., and Peppas N.A. Design of poly(ethylene glycol)-tethered copolymers as novel mucoadhesive drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics 63 1 (2006) 11-18
139. Shamlou P.A., Breen L.H., Bell W.V., Pollo M., and Thomas B.A. A new scaleable freeze-thaw technology for bulk protein solutions. Biotechnology and Applied Biochemistry 46 (2007) 13-26
140. Sinha V.R., and Trehan A. Biodegradable microspheres for protein delivery. Journal of Controlled Release 90 3 (2003) 261-280
141. Sipahigil O., Gursoy A., Cakalagaoglu F., and Okar I.T. Release behaviour and biocompatibility of drug-loaded pH sensitive particles. International Journal of Pharmaceutics 311 1-2 (2006) 130-138
142. Song Y., Wang Y., Thakur R., Meidan V.M., and Michniak B. Mucosal drug delivery: membranes, methodologies, and applications. Critical Reviews in Therapeutic Drug Carrier Systems 21 3 (2004) 195-256
143. Swenson E.C., and Curatolo W.J. Intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Advanced Drug Delivery Reviews 8 (1992) 39-92
144. Tanaka Y., Taki Y., Sakane T., Nadai T., Sezaki H., and Yamashita S. Characterization of drug transport through tight-junctional pathway in Caco-2 monolayer: comparison with isolated rat jejunum and colon. Pharmaceutical Research 12 (1995) 523-528
145. Thomas J.B., Tingsanchali J.H., Rosales A.M., Creecy C.M., McGinity J.W., and Peppas N.A. Dynamics of poly(ethylene glycol)-tethered, pH responsive networks. Polymer 48 17 (2007) 5042-5048
146. Torres-Lugo M., García M., Record R., and Peppas N.A. Physicochemical behavior and cytotoxic effects of P(MAA-g-EG) nanospheres for oral delivery of proteins. Journal of Controlled Release 80 (2002) 197-205
147. Torres-Lugo M., Garcia M., Record R., and Peppas N.A. pH-sensitive hydrogels as gastrointestinal tract absorption enhancers: transport mechanisms of salmon calcitonin and other model molecules using the Caco-2 cell model. Biotechnology Progress 18 3 (2002) 612-616
148. Torres-Lugo M., and Peppas N.A. Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin. Macromolecules 32 20 (1999) 6646-6651
149. Türker S., Onur E., and Ózer Y. Nasal route and drug delivery systems. Pharmacy World and Science 26 3 (2004) 137-142
150. Uchida T., Sakakibara S., Toida Y., Nagareya N., Yasuda N., and Matsuyama K. Rectal delivery of insulin using a bioadhesive hydrogel preparation containing lauric acid as an enhancer in rats. Pharmacy and Pharmacology Communications 5 (1999) 523-527
151. Ugwoke M.I., Verbeke N., and Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. Journal of Pharmacy and Pharmacology 53 1 (2001) 3-21
152. Wehren L.E. The role of the primary care physician in diagnosis and management of osteoporosis. International Journal of Fertility and Women's Medicine 47 3 (2002) 116-122
153. Werle M. Natural and synthetic polymers as inhibitors of drug efflux pumps. Pharmaceutical Research 25 3 (2008) 500-511
154. Werle M., and Bernkop-Schnurch A. Inhibition of enzymes and secretory transport. In: Touitou E., and Barry B.W. (Eds). Enhancement in Drug Delivery (2006), Taylor & Francis, Boca Raton, FL
155. Wood K.M., Stone G.M., and Peppas N.A. Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery. Biomacromolecules 9 4 (2008) 1293-1298
156. Xu H.-B., Huang K.-X., Zhu Y.-S., Gao Q.-H., Wu Q.-Z., Tian W.-Q., Sheng X.-Q., Chen Z.-X., and Gao Z.-H. Hypoglycaemic effect of a novel insulin buccal formulation on rabbits. Pharmacological Research 46 5 (2002) 459-467